Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis

Emil M DeGoma1, Benjamin French, Richard L Dunbar

  • 1Division of Cardiovascular Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, Heart and Vascular Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. Emil.deGoma@uphs.upenn.edu

Atherosclerosis
|August 1, 2012
PubMed

Insights

Intraindividual variability of C-reactive protein (CRP) is significantly greater than cholesterol measures. This suggests CRP levels fluctuate more than previously assumed, impacting risk assessment.

Area of Science:

  • Cardiovascular Disease Biomarkers
  • Inflammation Markers
  • Clinical Chemistry

Background:

  • Intraindividual variability of C-reactive protein (CRP) is not well-established.
  • Guidelines suggest CRP stability similar to cholesterol, but studies show greater CRP fluctuations.
  • The Multi-Ethnic Study of Atherosclerosis (MESA) is used to compare CRP variability with cholesterol measures.

Purpose of the Study:

  • To compare the intraindividual variability of C-reactive protein (CRP) with that of cholesterol measures.
  • To assess the stability of serial CRP values in a large, multi-ethnic cohort.
  • To determine if CRP variability impacts cardiovascular risk stratification.

Main Methods:

  • Analyzed CRP, total cholesterol (TC), and non-HDL-cholesterol (non-HDL-C) in 760 MESA participants.
  • Excluded participants with confounding comorbidities or medications.
  • Calculated intraclass correlation coefficients (ICC) to quantify variability.
  • Cross-classified baseline and follow-up tertiles to assess fluctuation.

Main Results:

  • CRP's multivariable-adjusted ICC (0.62) was significantly lower than TC (0.75) and non-HDL-C (0.76).
  • 51% of participants in the highest baseline CRP tertile showed discordant follow-up values.
  • Among those with CRP > 3 mg/L, 69% later fell into a lower risk category.

Conclusions:

  • Intraindividual variation of CRP is significantly greater than that of cholesterol measures in the MESA cohort.
  • The findings challenge the assumption of CRP stability for serial measurements.
  • Further research with shorter measurement intervals is recommended to understand CRP variability.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...